Effect of anemia on hemorrhagic complications and mortality following percutaneous coronary intervention.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  American Journal of Cardiology

• Publication date

  2007-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/J.AMJCARD.2007.01.027PMID 17531572
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Anemia of chronic disease.

  2005cited by this paper
• Physiologic aspects of anemia.

  2004cited by this paper
• Prognostic Implication of Anemia on In-Hospital Outcomes After Percutaneous Coronary Intervention

  2004cited by this paper
• Anemia is an independent predictor of mortality after percutaneous coronary intervention.

  2004cited by this paper
• Impact of anemia in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: analysis from the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) Trial.

  2004cited by this paper
• Double jeopardy of renal insufficiency and anemia in patients undergoing percutaneous coronary interventions.

  2004cited by this paper
• Predictors of major bleeding in acute coronary syndromes: the Global Registry of Acute Coronary Events (GRACE).

  2004cited by this paper
• Long-term efficacy of bivalirudin and provisional glycoprotein IIb/IIIa blockade vs heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary revascularization: REPLACE-2 randomized trial.

  2004cited by this paper
• Impact of anemia on outcomes of patients undergoing percutaneous coronary interventions.

  2004cited by this paper
• Incidence, predictors, and prognostic implications of bleeding and blood transfusion following percutaneous coronary interventions.

  2003cited by this paper
• Bivalirudin and provisional glycoprotein IIb/IIIa blockade compared with heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary intervention: REPLACE-2 randomized trial.

  2003cited by this paper
• Predictors of major bleeding in acute coronary syndromes: the Global Registry of Acute Coronary Events (GRACE)

  2003cited by this paper
• Acute dilutional anemia and critical left anterior descending coronary artery stenosis impairs end organ oxygen delivery.

  1996cited by this paper
• Thrombolysis in Myocardial Infarction (TIMI) Trial--phase I: hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinase.

  1988cited by this paper

• Traumatic bleeding and mortality in mice are intensified by iron deficiency anemia and can be rescued with tranexamic acid

  2024cites this paper
• Association between anaemia and long-term prognosis in patients with non-ST segment elevation myocardial infarction

  2023cites this paper
• Incorporation of Laboratory Test Biomarkers Into Dual Antiplatelet Therapy Score Improves Prediction of Ischemic and Bleeding Events in Post-percutaneous Coronary Intervention Patients

  2022cites this paper
• Prognostic Value of the Pattern of Non-Adherence to Anti-Platelet Regimen in Stented Patients (PARIS) Bleeding Risk Score for Long-Term Mortality After Percutaneous Coronary Intervention.

  2022cites this paper
• Clinical Characteristics and Long-Term Outcomes of Patients With Differing Haemoglobin Levels Undergoing Semi-Urgent and Elective Percutaneous Coronary Intervention in an Asian Population

  2022cites this paper
• Correlation of the ORBIT Score With 30-Day Mortality in Patients With ST-Segment Elevation Myocardial Infarction

  2020cites this paper
• Long-term impact of baseline anaemia on clinical outcomes following percutaneous coronary intervention in stable angina

  2020cites this paper
• Prognostic Impact of Baseline Hemoglobin Levels on Long‐Term Thrombotic and Bleeding Events After Percutaneous Coronary Interventions

  2019influential citation
• Impact of Baseline Anemia in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention: A Prespecified Analysis From the VALIDATE‐SWEDEHEART Trial

  2019cites this paper
• Impact of anemia on percutaneous coronary intervention in Chinese patients: A large single center data

  2018cites this paper
• Outcomes of Percutaneous Coronary Interventions in Patients With Anemia Presenting With Acute Coronary Syndrome

  2018cites this paper
• Influence of Age and Gender on Clinical Outcomes Following Percutaneous Coronary Intervention for Acute Coronary Syndromes.

  2017cites this paper
• Meta-Analysis of the Prognostic Impact of Anemia in Patients Undergoing Percutaneous Coronary Intervention.

  2016cites this paper
• Impact of anemia on long-term ischemic events and bleeding events in patients undergoing percutaneous coronary intervention: a system review and meta-analysis.

  2015influential citation
• Blood transfusion after percutaneous coronary intervention and risk of subsequent adverse outcomes: a systematic review and meta-analysis.

  2015cites this paper
• Impact of Anemia and Dual Antiplatelet Therapy on Mortality in Patients Undergoing Percutaneous Coronary Intervention with Drug-Eluting Stents

  2015cites this paper
• Association between preprocedural hemoglobin level and 1-year outcome of elective percutaneous coronary intervention

  2014cites this paper
• Effect of anemia on frequency of short- and long-term clinical events in acute coronary syndromes (from the Acute Catheterization and Urgent Intervention Triage Strategy Trial).

  2014cites this paper
• Frequency of and risk factors for complications after liver radiofrequency ablation under CT fluoroscopic guidance in 1500 sessions: single-center experience.

  2013cites this paper
• Bivalirudin in acute coronary syndromes and percutaneous coronary intervention: should we use it?

  2013cites this paper
• Transradial Approach for Chronic Total Occlusion Percutaneous Coronary Intervention.

  2012cites this paper
• Risk factors for postpartum hemorrhage in a cohort of 6011 Italian women.

  2012cites this paper
• Can the presence of anemia on admission improve the predictive value of the GRACE risk score for short- and medium-term mortality after acute coronary syndrome?

  2012cites this paper
• Impact of diabetes mellitus on long-term clinical outcomes of patients on chronic hemodialysis after percutaneous coronary intervention.

  2012cites this paper
• [Can the presence of anemia on admission improve the predictive value of the GRACE risk score for short- and medium-term mortality after acute coronary syndrome?].

  2012cites this paper
• [Anemia as a risk factor in patients with heart attack after interventional treatment].

  2011cites this paper
• Incidence, prognostic impact, and influence of antithrombotic therapy on access and nonaccess site bleeding in percutaneous coronary intervention.

  2011cites this paper
• Complicaciones hemorrágicas del tratamiento de los síndromes coronarios agudos

  2011cites this paper
• Comment to article Niedokrwistość jako czynnik ryzyka u pacjentów z zawałem serca leczonych interwencyjnie

  2011cites this paper
• Six-month mortality and cardiac catheterization in non-ST-segment elevation myocardial infarction patients with anemia

  2011cites this paper
• The significance of anaemia in patients with acute ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention.

  2011cites this paper
• When Blood Is Not an Option: Factors Affecting Survival After the Use of a Hemoglobin-Based Oxygen Carrier in 54 Patients with Life-Threatening Anemia

  2010cites this paper
• Bridging the gap between clinical trials of antiplatelet therapies and applications among elderly patients.

  2010cites this paper
• Capítulo 21 – Determinantes fisiológicos de la transfusión de hematíes. Umbral transfusional

  2010cites this paper
• Impact of anemia on clinical outcomes of patients with ST-segment elevation myocardial infarction in relation to gender and adjunctive antithrombotic therapy (from the HORIZONS-AMI trial).

  2010cites this paper
• Relationship between baseline haemoglobin and major bleeding complications in acute coronary syndromes.

  2010cites this paper
• The relationship between bleeding and adverse outcomes in ACS and PCI: pharmacologic and nonpharmacologic modification of risk.

  2010cites this paper
• Incidence, range, and clinical effect of hemoglobin changes within 24 hours after transradial coronary stenting.

  2010cites this paper
• Anemia, hemorrhage, and transfusion in percutaneous coronary intervention, acute coronary syndromes, and ST-segment elevation myocardial infarction.

  2009cites this paper
• Anemia and blood transfusion: Prognostic implications in patients undergoing contemporary percutaneous coronary intervention

  2009cites this paper
• [Percentage of transradial approach for interventional cardiology in the world and learning the technique].

  2009cites this paper
• Impact of bivalirudin on in‐hospital bleeding and six‐month outcomes in octogenarians undergoing percutaneous coronary intervention

  2009cites this paper
• Hematologic parameters, atherosclerotic progression, and prognosis in patients with previous coronary artery bypass grafting (from the Post CABG Trial).

  2009cites this paper
• Predictors and impact of bleeding complications in percutaneous coronary intervention, acute coronary syndromes, and ST-segment elevation myocardial infarction.

  2009cites this paper
• The clinical significance of hematocrit values before and after percutaneous coronary intervention.

  2009cites this paper
• Anemia for risk assessment of patients with acute coronary syndromes.

  2009cites this paper
• Incidence, predictors, and clinical impact of bleeding after transradial coronary stenting and maximal antiplatelet therapy.

  2009cites this paper
• Tug of war.

  2009cites this paper
• Acute Coronary Syndromes and Percutaneous Coronary Interventions: impact of bleeding and blood transfusion.

  2009cites this paper
• Impact of bivalirudin use on outcomes in nonagenarians undergoing percutaneous coronary intervention.

  2009cites this paper
• Acute coronary syndromes and percutaneous coronary interventions

  2009cites this paper
• Effect of blood hematocrit and erythrocyte deformability on adenosine 5'-diphosphate platelet reactivity in patients with acute coronary syndromes on dual antiplatelet therapy.

  2009cites this paper
• Antiplatelet therapy in percutaneous coronary intervention: A critical review of the 2007 AHA/ACC/SCAI guidelines and beyond

  2009cites this paper
• CORONARY ARTERY DISEASE Impact of Bivalirudin Use on Outcomes in Nonagenarians Undergoing Percutaneous Coronary Intervention

  2009cites this paper
• Risk Factors for Major Bleeding in Patients With Heparin-induced Thrombocytopenia Treated With Argatroban: A Retrospective Study

  2008cites this paper
• The year in interventional cardiology.

  2008cites this paper
• The DELTA MI ( Direct Inhibition of Protein Kinase Enyzme to Limit Total Infarct Size in Acute Myocardial nfarction ) trial

  2008cites this paper
• Percutaneous coronary intervention in patients with acute coronary syndrome: focus on bivalirudin

  2008cites this paper
• Decreased complication rates using the transradial compared to the transfemoral approach in percutaneous coronary intervention in the era of routine stenting and glycoprotein platelet IIb/IIIa inhibitor use: a large single-center experience.

  2008cites this paper
• Hemodilution and anemia in patients with cardiac disease: what is the safe limit?

  2008cites this paper
• Comparison of hemorheological variables in ST-elevation myocardial infarction versus those in non-ST-elevation myocardial infarction or unstable angina pectoris.

  2008cites this paper
• Increased major bleeding complications related to triple antithrombotic therapy usage in patients with atrial fibrillation undergoing percutaneous coronary artery stenting.

  2008cites this paper
• High-risk Acute Coronary Syndrome Patients with Non-ST-Elevation Myocardial Infarction: Definition and Treatment

  2008influential citation
• Bleeding is bad.... isn't it?

  2007cites this paper
• Bleeding Complications in Acute Coronary Syndromes and Percutaneous Coronary Intervention: Predictors, Prognostic Significance, and Paradigms for Reducing Risk

  2007cites this paper
• Predictors and impact of major hemorrhage on mortality following percutaneous coronary intervention from the REPLACE-2 Trial.

  2007cites this paper